U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
114451114451Remote Ischaemic Preconditioning for Heart Surgery (RIPHeart-Study)TerminatedNo Results AvailableMyocardial Injury|MortalityProcedure: Remote Ischemic Preconditioning|Procedure: Control/sham procedure (blood pressure cuff)https://ClinicalTrials.gov/show/NCT01067703
114452114452Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's SarcomaActive, not recruitingNo Results AvailableKaposi's SarcomaDrug: Indinavir in association with Vinblastina +/- Bleomicinahttps://ClinicalTrials.gov/show/NCT01067690
114453114453Rescue Emetic Therapy for Children Having Elective SurgeryRecruitingNo Results AvailablePost Operative Nausea and Vomiting|Rescue Emetic TherapyDrug: Metaclopramide|Drug: Ondansetron|Drug: diphenhydramine|Drug: Salinehttps://ClinicalTrials.gov/show/NCT01067677
114454114454Prognostic Value of Progesterone for In Vitro Fertilization (IVF) OutcomeCompletedNo Results AvailableSubfertilityhttps://ClinicalTrials.gov/show/NCT01067664
114455114455Comparison of Casting Materials for the Treatment of Clubfoot Using the Ponseti MethodCompletedNo Results AvailableClubfoot|Ponseti Method|Talipes Equinovarus|CastingDevice: Plaster of Paris (POP) casting using the Ponseti Method|Device: Semi-Rigid Fiberglass softcast using the Ponseti Methodhttps://ClinicalTrials.gov/show/NCT01067651
114456114456The Effect of Tranexamic Acid on Postoperative Blood Loss and Coagulation in Patients With Preoperative Anemia Undergoing Off-Pump Coronary Artery Bypass Graft; Double Blind Randomized Control StudyCompletedNo Results AvailableCoronary Artery Occlusive DiseaseDrug: Tranexamic Acidhttps://ClinicalTrials.gov/show/NCT01067638
114457114457Endoscopic Bariatric Stapling Pilot StudyEnrolling by invitationNo Results AvailableObesityDevice: TOGA® Systemhttps://ClinicalTrials.gov/show/NCT01067625
114458114458Novel Determinants and Measures of Smokeless Tobacco Use: Study 2RecruitingNo Results AvailableTobacco Use Disorder|Nicotine DependenceOther: Low nicotine|Other: Medium nicotine|Other: High nicotinehttps://ClinicalTrials.gov/show/NCT01067599
114459114459Novel Determinants and Measures of Smokeless Tobacco Use: Study 1CompletedNo Results AvailableSmokeless Tobacco Use|Tobacco Dependencehttps://ClinicalTrials.gov/show/NCT01067586
114460114460The Role of Serum Leptin Levels in Multiple Sclerosis Disease Activity While on Interferon Beta 1a (Rebif) TreatmentCompletedNo Results AvailableMultiple Sclerosishttps://ClinicalTrials.gov/show/NCT01067573
114461114461Measuring Cerebrospinal Fluid (CSF) Glucose Levels in Patients Under Going an Elective Cesarean Section With Spinal AnesthesiaCompletedNo Results AvailableSpinal Anesthesiahttps://ClinicalTrials.gov/show/NCT01067560
114462114462A Trial of Iron Replacement in Patients With Iron Deficiency.CompletedNo Results AvailableIron Deficiency|Inflammatory Bowel DiseaseDrug: Iron Sucrose.|Drug: Iron sucrosehttps://ClinicalTrials.gov/show/NCT01067547
114463114463Bronchodilator Responsiveness in Healthy Young Adults Using Forced Oscillations Technique (FOT)CompletedNo Results AvailableBronchodilationDrug: Salbutamolhttps://ClinicalTrials.gov/show/NCT01067534
114464114464A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to PlaceboActive, not recruitingNo Results AvailableRelapsing Remitting Multiple SclerosisDrug: Glatiramer acetate (GA)|Other: Placebohttps://ClinicalTrials.gov/show/NCT01067521
114465114465Effects of Naturally Silicon-Rich Water on Bone Metabolism in WomenCompletedNo Results AvailableBone Diseases, MetabolicOther: Fiji Waterhttps://ClinicalTrials.gov/show/NCT01067508
114466114466Adapted Cardiac Rehabilitation After StrokeCompletedNo Results AvailableStrokeBehavioral: Cardiac rehabilitationhttps://ClinicalTrials.gov/show/NCT01067495
114467114467The Performances of Spectral Domain Optical Coherence Tomography (OCT) for Distinguishing Glaucomatous EyesCompletedNo Results AvailableGlaucoma Patient|Glaucoma Suspect Patient|Normal Population|RNFL Thickness by Location|Macular Thickness by Locationhttps://ClinicalTrials.gov/show/NCT01067482
114468114468Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)Active, not recruitingNo Results AvailableBrain Cancer|GlioblastomaDrug: Standard Dose Bevacizumab|Drug: Low Dose Bevacizumab|Drug: Lomustinehttps://ClinicalTrials.gov/show/NCT01067469
114469114469Comprehensive Cardiothoracic Dual Source CT for the Early Triage of Patients With Acute Chest PainCompletedHas ResultsChest Pain SyndromeRadiation: Comprehensive Cardiothoracic CT armhttps://ClinicalTrials.gov/show/NCT01067456
114470114470Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern AfricaCompletedNo Results AvailablePrimary Visceral LeishmaniasisDrug: Liposomal amphotericin B (AmBisome®) and sodium stibogluconate|Drug: Liposomal amphotericin B + miltefosine|Drug: Miltefosinehttps://ClinicalTrials.gov/show/NCT01067443
114471114471Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis (RA)Not yet recruitingNo Results AvailableRheumatoid ArthritisDrug: Etoricoxib|Drug: Diclofenachttps://ClinicalTrials.gov/show/NCT01067430
114472114472Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected PatientsActive, not recruitingNo Results AvailableHIV InfectionsDrug: Hydroxychloroquine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01067417
114473114473TIV Infant/Toddler Response Evaluation (TITRE)- Follow-up & Focus on Influenza BEnrolling by invitationNo Results AvailableInfluenzaBiological: Trivalent inactivated influenza vaccinehttps://ClinicalTrials.gov/show/NCT01067404
114474114474Effect of Tadalafil (Cialis) on the Cardiovascular System of Spinal Cord Injury (SCI) MalesCompletedNo Results AvailableHypotension|Spinal Cord InjuryDrug: tadalafil|Drug: placebohttps://ClinicalTrials.gov/show/NCT01067391
114475114475Peer Debriefing Versus Instructor Debriefing for Interprofessional Simulation Based EducationActive, not recruitingNo Results AvailableCrisis Resource ManagementOther: Peer-led debriefing|Other: Expert instructor debriefinghttps://ClinicalTrials.gov/show/NCT01067378
114476114476Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary HypogonadismCompletedNo Results AvailableSecondary HypogonadismDrug: Androxal|Drug: Androxalhttps://ClinicalTrials.gov/show/NCT01067365
114477114477A Trial to Evaluate the Correlation Between Spontaneous Catch-up Growth, Clinical Response to Saizen (Recombinant Human Growth Hormone, r-hGH) and Gene Expression Profiling in Children Small for Gestational Age (SGA)TerminatedHas ResultsInfant, Small for Gestational AgeDrug: Recombinant human growth hormone (r-hGH)https://ClinicalTrials.gov/show/NCT01067352
114478114478Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM IIIActive, not recruitingNo Results AvailableEndothelial DysfunctionDrug: darapladib|Drug: placebohttps://ClinicalTrials.gov/show/NCT01067339
114479114479The Effect of Tekturna on Endothelial Function and Endothelial Progenitor Cells in Patients With Early AtherosclerosisTerminatedHas ResultsEndothelial DysfunctionDrug: Aliskiren|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01067326
114480114480Continuous Hemodialysis With an Enhanced Middle Molecule Clearance MembraneCompletedNo Results AvailableSeptic ShockDevice: Dialyzer Ultraflux EMiC2|Device: Dialyzer Ultraflux AV1000Shttps://ClinicalTrials.gov/show/NCT01067313

* Görseller ve İçerik tekif hakkına sahip olabilir